TD Asset Management »

Bridgebio Oncology Therapeut shares owned by TD Asset Management

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 130k 11.58

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Enbridge (ENB)
Cibc Cad (CM)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Brookfield Corp Cl A Ltd Vt Sh (BN)
JPMorgan Chase & Co. (JPM)
Agnico (AEM)

View all positions for TD Asset Management

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut